Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): part I. Albumin-bound betulinic acid nanoparticles (ABBns)

References

• Ahmed-Ouameur A, Diamantoglou S, Nafisi S, Sedaghat-Herati MR, Carpentier R, Tajmir-Riahi HA. The effects of drug complexation on the stability and conformation of human serum albumin: Protein unfolding. Cell Biochem Biophys, 2006;45(2):203–13.
   PubMed Web of Science ®Google Scholar
• Alvi M, Chatterjee P. A prospective analysis of co-processed non-ionic surfactants in enhancing permeability of a model hydrophilic drug. AAPS PharmSciTech, 2014;15(2):339–53.
   PubMed Web of Science ®Google Scholar
• Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. N Engl J Med, 2005;353(17):1784–92.
   PubMed Web of Science ®Google Scholar
• Chen W, Bing G, Hao W, Jun P, Weiyue L, Huimin H. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles. Int J Pharm, 2008;362:133–40.
   PubMed Web of Science ®Google Scholar
• Cheng X, Joseph ET, Richard VB, Young GS, Barry SL, Adaline CS. Quantitative analysis of betulinic acid in mouse, rat and dog plasma using electrospray liquid chromatography/mass spectrometry. Rapid Commun Mass Spec, 2003;17(4):2089–92.
   PubMed Web of Science ®Google Scholar
• Cortes J, Saura C. Nanoparticle albumin-bound (nab™)-paclitaxel: Improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer. Eur J Cancer Suppl, 2010;8(1):1–10.
   Web of Science ®Google Scholar
• Elusiyan C, Msagati T, Shode F, Mamba B. Measurements of distribution coefficients and lipophilicity values for oleanolic acid and betulinic acid extracted from indigenous plants by hollow fiber supported liquid membrane. Bull Chem Soc Ethiop, 2011;25(3):321–32.
   Web of Science ®Google Scholar
• Elzoghby AO, Samy WM, Elgindy NA. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release, 2012;157(2):168–80.
   PubMed Web of Science ®Google Scholar
• Erkula SV, Srivari Y, Chatterjee P. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles. 2016. [Epub ahead of print].
   Google Scholar
• Fanali G, Masi A, Trezza V, Marino M, Fasanoa M, Ascenzi P. Human serum albumin: From bench to bedside. Mol Aspects Med, 2012;33(3):209–90.
   PubMed Web of Science ®Google Scholar
• Fasano M, Curry S, Terreno E, Galliano M, Fanali G, Narciso P, Notari S, Ascenzi P. The extraordinary ligand binding properties of human serum albumin. IUBMB Life, 2005;57(12):787–96.
   PubMed Web of Science ®Google Scholar
• Glatz JFC, Luiken JJFP, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: Implications for metabolic diseases. Physiol Rev, 2010;90:367–417.
   PubMed Web of Science ®Google Scholar
• Gokara M, Sudhamalla B, Amooru D, Subramanyam R. Molecular interaction studies of trimethoxy flavone with human serum albumin. PLoS One, 2010;5(1):e8834.
   PubMed Web of Science ®Google Scholar
• Jäger S, Karin W, Uwe P, Armin S. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album. Planta Med, 2007;73(2):157–62.
   PubMed Web of Science ®Google Scholar
• Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release, 2008;132(3):171–83.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release, 2000;65:271–84.
   PubMed Web of Science ®Google Scholar
• Malleda C, Ahalawat N, Gokara M, Subramanyam R. Molecular dynamics simulation studies of betulinic acid with human serum albumin. J Mol Model, 2012;18(6):2589–97.
   PubMed Web of Science ®Google Scholar
• Miriam RP, Oropesa NR, Tirso P, Renaux WL, Pérez GA. Physico-chemical studies of molecular interactions between non-ionic surfactants and bovine serum albumin. Colloids Surf B Biointerfaces, 2010;75(5):282–9.
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev, 2011;37(7):559–66.
   PubMed Web of Science ®Google Scholar
• Neumann E, Frei E, Funk D, Becker MD, Schrenk HH, Muller-Ladner U, Fiehn C. Native albumin for targeted drug delivery. Expert Opin Drug Deliv, 2010;7:915–25.
   PubMed Web of Science ®Google Scholar
• Podhajcer OL, Benedetti L, Grotto MR, Prada F, Salvatierra E, Llera AS. The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev, 2008;27(3):523–37.
   PubMed Web of Science ®Google Scholar
• Rangel Yagui CO, Pessoa A Jr, Tavares LC. Micellar solubilization of drugs. J Pharm Pharm Sci, 2005;8(2):147–63.
   PubMed Web of Science ®Google Scholar
• Schubert W, Frank PG, Razani B, Park DS, Chow CW, Lisanti MP. Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo. J Biol Chem, 2001;276(52):48619–22.
   PubMed Web of Science ®Google Scholar
• Subramanyam R, Gollapudi A, Bonigala P, Chinnaboina M, Amooru DM. Betulinic acid binding to human serum albumin: A study of protein conformation and binding affinity. J Photochem Photobiol B Biol, 2009;94(1):9–12.
   Web of Science ®Google Scholar
• Udeani GO, Zhao GM, Shin YG, Cooke B, Graham J, Beecher CW, Douglas K, Pezzuto JM. Pharmacokinetics and tissue distribution of betulinic acid in CD-1 mice. Biopharm Drug Dispos, 1999;20(8):379–83.
   PubMed Web of Science ®Google Scholar
• Ujhelyi Z, Fenyvesi F, Váradi J, Fehér P, Kiss T, Veszelka S, Deli M, Vecsernyés M, Bácskay I. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer. Eur J Pharm Sci, 2012;47(3):564–73.
   PubMed Web of Science ®Google Scholar
• Yu M, Ocando JE, Trombetta L, Chatterjee P. Molecular interaction studies of amorphous solid dispersions of the antimelanoma agent betulinic acid. AAPS PharmSciTech, 2015;16(2):384–95.
   PubMed Web of Science ®Google Scholar
• Zuco V, Supino R, Righetti SC, Cleris L, Marchesi E, Gambacorti-Passerini C. Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett, 2002;175(1):17–25.
   PubMed Web of Science ®Google Scholar